302 related articles for article (PubMed ID: 30676753)
1. Snapshots of Iron Speciation: Tracking the Fate of Iron Nanoparticle Drugs via a Liquid Chromatography-Inductively Coupled Plasma-Mass Spectrometric Approach.
Neu HM; Alexishin SA; Brandis JEP; Williams AMC; Li W; Sun D; Zheng N; Jiang W; Zimrin A; Fink JC; Polli JE; Kane MA; Michel SLJ
Mol Pharm; 2019 Mar; 16(3):1272-1281. PubMed ID: 30676753
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the Physicochemical Properties of the Iron Nanoparticle Drug Products: Brand and Generic Sodium Ferric Gluconate.
Brandis JEP; Kihn KC; Taraban MB; Schnorr J; Confer AM; Batelu S; Sun D; Rodriguez JD; Jiang W; Goldberg DP; Langguth P; Stemmler TL; Yu YB; Kane MA; Polli JE; Michel SLJ
Mol Pharm; 2021 Apr; 18(4):1544-1557. PubMed ID: 33621099
[TBL] [Abstract][Full Text] [Related]
3. Determination of Non-Transferrin Bound Iron, Transferrin Bound Iron, Drug Bound Iron and Total Iron in Serum in a Rats after IV Administration of Sodium Ferric Gluconate Complex by Simple Ultrafiltration Inductively Coupled Plasma Mass Spectrometric Detection.
Matta MK; Beekman CR; Gandhi A; Narayanasamy S; Thomas CD; Mohammad A; Stewart S; Xu L; Chockalingam A; Shea K; Patel V; Rouse R
Nanomaterials (Basel); 2018 Feb; 8(2):. PubMed ID: 29439469
[TBL] [Abstract][Full Text] [Related]
4. Sodium ferric gluconate (SFG) in complex with sucrose for IV infusion: bioequivalence of a new generic product with the branded product in healthy volunteers.
Baribeault D
Curr Med Res Opin; 2011 Aug; 27(8):1653-7. PubMed ID: 21714710
[TBL] [Abstract][Full Text] [Related]
5. Air-Liquid Interface Cell Exposures to Nanoparticle Aerosols.
Lewinski NA; Liu NJ; Asimakopoulou A; Papaioannou E; Konstandopoulos A; Riediker M
Methods Mol Biol; 2017; 1570():301-313. PubMed ID: 28238146
[TBL] [Abstract][Full Text] [Related]
6. Critical nanomaterial attributes of iron-carbohydrate nanoparticles: Leveraging orthogonal methods to resolve the 3-dimensional structure.
Krupnik L; Joshi P; Kappler A; Flühmann B; Alston AB; Digigow R; Wick P; Neels A
Eur J Pharm Sci; 2023 Sep; 188():106521. PubMed ID: 37423578
[TBL] [Abstract][Full Text] [Related]
7. A comparative study of the physicochemical properties of iron isomaltoside 1000 (Monofer), a new intravenous iron preparation and its clinical implications.
Jahn MR; Andreasen HB; Fütterer S; Nawroth T; Schünemann V; Kolb U; Hofmeister W; Muñoz M; Bock K; Meldal M; Langguth P
Eur J Pharm Biopharm; 2011 Aug; 78(3):480-91. PubMed ID: 21439379
[TBL] [Abstract][Full Text] [Related]
8. Short-term stability of a new generic sodium ferric gluconate in complex with sucrose.
Baribeault D
Curr Med Res Opin; 2011 Dec; 27(12):2241-3. PubMed ID: 21992082
[TBL] [Abstract][Full Text] [Related]
9. Introducing Specificity to Iron Oxide Nanoparticle Imaging by Combining
Masthoff M; Buchholz R; Beuker A; Wachsmuth L; Kraupner A; Albers F; Freppon F; Helfen A; Gerwing M; Höltke C; Hansen U; Rehkämper J; Vielhaber T; Heindel W; Eisenblätter M; Karst U; Wildgruber M; Faber C
Nano Lett; 2019 Nov; 19(11):7908-7917. PubMed ID: 31556617
[TBL] [Abstract][Full Text] [Related]
10. Regulatory challenges and approaches to characterize nanomedicines and their follow-on similars.
Mühlebach S; Borchard G; Yildiz S
Nanomedicine (Lond); 2015 Mar; 10(4):659-74. PubMed ID: 25723097
[TBL] [Abstract][Full Text] [Related]
11. Liquid chromatography coupled with inductively coupled plasma mass spectrometry in the pharmaceutical industry: selected examples.
Marshall PS; Leavens B; Heudi O; Ramirez-Molina C
J Chromatogr A; 2004 Nov; 1056(1-2):3-12. PubMed ID: 15595526
[TBL] [Abstract][Full Text] [Related]
12. Safety and Toxicological Considerations of Nanomedicines: The Future Directions.
Patel P; Shah J
Curr Clin Pharmacol; 2017; 12(2):73-82. PubMed ID: 28486906
[TBL] [Abstract][Full Text] [Related]
13. Iron Oxide Nanoparticle Formulations for Supplementation.
Pai AB
Met Ions Life Sci; 2019 Jan; 19():. PubMed ID: 30855107
[TBL] [Abstract][Full Text] [Related]
14. Complexity of intravenous iron nanoparticle formulations: implications for bioequivalence evaluation.
Pai AB
Ann N Y Acad Sci; 2017 Nov; 1407(1):17-25. PubMed ID: 29027212
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo DFO-chelatable labile iron release profiles among commercially available intravenous iron nanoparticle formulations.
Pai AB; Pai MP; Meyer DE; Bales BC; Cotero VE; Zheng N; Jiang W
Regul Toxicol Pharmacol; 2018 Aug; 97():17-23. PubMed ID: 29857115
[TBL] [Abstract][Full Text] [Related]
16. Comparative Evaluation of U.S. Brand and Generic Intravenous Sodium Ferric Gluconate Complex in Sucrose Injection: In Vitro Cellular Uptake.
Wu M; Sun D; Tyner K; Jiang W; Rouse R
Nanomaterials (Basel); 2017 Dec; 7(12):. PubMed ID: 29244729
[TBL] [Abstract][Full Text] [Related]
17. Liquid chromatography-inductively coupled plasma mass spectrometry.
Sutton KL; Caruso JA
J Chromatogr A; 1999 Sep; 856(1-2):243-58. PubMed ID: 10526791
[TBL] [Abstract][Full Text] [Related]
18. Factors influencing safety and efficacy of intravenous iron-carbohydrate nanomedicines: From production to clinical practice.
Nikravesh N; Borchard G; Hofmann H; Philipp E; Flühmann B; Wick P
Nanomedicine; 2020 Jun; 26():102178. PubMed ID: 32145382
[TBL] [Abstract][Full Text] [Related]
19. Core size determination and structural characterization of intravenous iron complexes by cryogenic transmission electron microscopy.
Wu Y; Petrochenko P; Chen L; Wong SY; Absar M; Choi S; Zheng J
Int J Pharm; 2016 May; 505(1-2):167-74. PubMed ID: 27001529
[TBL] [Abstract][Full Text] [Related]
20. LA-ICP-MS Allows Quantitative Microscopy of Europium-Doped Iron Oxide Nanoparticles and is a Possible Alternative to Ambiguous Prussian Blue Iron Staining.
Scharlach C; Müller L; Wagner S; Kobayashi Y; Kratz H; Ebert M; Jakubowski N; Schellenberger E
J Biomed Nanotechnol; 2016 May; 12(5):1001-10. PubMed ID: 27305821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
